BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14626429)

  • 1. Viruses as hijackers of PML nuclear bodies.
    Möller A; Schmitz ML
    Arch Immunol Ther Exp (Warsz); 2003; 51(5):295-300. PubMed ID: 14626429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA viruses and viral proteins that interact with PML nuclear bodies.
    Everett RD
    Oncogene; 2001 Oct; 20(49):7266-73. PubMed ID: 11704855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.
    Komatsu T; Nagata K; Wodrich H
    J Virol; 2016 Feb; 90(3):1657-67. PubMed ID: 26608315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interactions between PML nuclear bodies and small and medium size DNA viruses.
    Ryabchenko B; Šroller V; Horníková L; Lovtsov A; Forstová J; Huérfano S
    Virol J; 2023 May; 20(1):82. PubMed ID: 37127643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
    Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
    PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
    Chelbi-Alix MK; de Thé H
    Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.
    Block GJ; Eskiw CH; Dellaire G; Bazett-Jones DP
    Mol Cell Biol; 2006 Dec; 26(23):8814-25. PubMed ID: 16966371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R; Pandolfi PP
    Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein.
    Ariumi Y; Ego T; Kaida A; Matsumoto M; Pandolfi PP; Shimotohno K
    Oncogene; 2003 Mar; 22(11):1611-9. PubMed ID: 12642864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
    Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
    J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML nuclear bodies and apoptosis.
    Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
    Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication.
    Jul-Larsen A; Visted T; Karlsen BO; Rinaldo CH; Bjerkvig R; Lønning PE; Bøe SO
    Exp Cell Res; 2004 Aug; 298(1):58-73. PubMed ID: 15242762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial and temporal organization of adeno-associated virus DNA replication in live cells.
    Fraefel C; Bittermann AG; Büeler H; Heid I; Bächi T; Ackermann M
    J Virol; 2004 Jan; 78(1):389-98. PubMed ID: 14671120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.
    Müller S; Dejean A
    J Virol; 1999 Jun; 73(6):5137-43. PubMed ID: 10233977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.
    Bienkowska-Haba M; Luszczek W; Keiffer TR; Guion LGM; DiGiuseppe S; Scott RS; Sapp M
    Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27860076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
    Berscheminski J; Wimmer P; Brun J; Ip WH; Groitl P; Horlacher T; Jaffray E; Hay RT; Dobner T; Schreiner S
    J Virol; 2014 Jun; 88(11):6076-92. PubMed ID: 24623443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
    Lai HK; Borden KL
    Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.